Extracellular Matrix Alterations and the Antifibrotic Role of Mycophenolate Mofetil in a Model of Peyronie’s Disease

0
8
Scientists evaluated ECM alterations in a rat model of Peyronie’s disease induced by transforming growth factor beta and to assess the potential antifibrotic effects of mycophenolate mofetil.
[Journal of Histochemistry & Cytochemistry]
Abstract